trical pharm ltd
trical pharm ltd Company Information
Company Number
10260671
Next Accounts
Dec 2024
Industry
Wholesale of pharmaceutical goods
Directors
Shareholders
neha pabari
Group Structure
View All
Contact
Registered Address
315 dalgin place, cambell park, MK9 4AS
Website
-trical pharm ltd Estimated Valuation
Pomanda estimates the enterprise value of TRICAL PHARM LTD at £36.4k based on a Turnover of £121k and 0.3x industry multiple (adjusted for size and gross margin).
trical pharm ltd Estimated Valuation
Pomanda estimates the enterprise value of TRICAL PHARM LTD at £0 based on an EBITDA of £-456 and a 2.91x industry multiple (adjusted for size and gross margin).
trical pharm ltd Estimated Valuation
Pomanda estimates the enterprise value of TRICAL PHARM LTD at £92 based on Net Assets of £47 and 1.97x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Trical Pharm Ltd Overview
Trical Pharm Ltd is a dissolved company that was located in cambell park, MK9 4AS with a Companies House number of 10260671. It operated in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in July 2016, it's largest shareholder was neha pabari with a 100% stake. The last turnover for Trical Pharm Ltd was estimated at £121k.
Upgrade for unlimited company reports & a free credit check
Trical Pharm Ltd Health Check
Pomanda's financial health check has awarded Trical Pharm Ltd a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
8 Weak
Size
annual sales of £121k, make it smaller than the average company (£27m)
- Trical Pharm Ltd
£27m - Industry AVG
Growth
3 year (CAGR) sales growth of -4%, show it is growing at a slower rate (4.8%)
- Trical Pharm Ltd
4.8% - Industry AVG
Production
with a gross margin of 12.3%, this company has a higher cost of product (23%)
- Trical Pharm Ltd
23% - Industry AVG
Profitability
an operating margin of -0.4% make it less profitable than the average company (4.2%)
- Trical Pharm Ltd
4.2% - Industry AVG
Employees
with 1 employees, this is below the industry average (44)
- Trical Pharm Ltd
44 - Industry AVG
Pay Structure
on an average salary of £59.6k, the company has an equivalent pay structure (£59.6k)
- Trical Pharm Ltd
£59.6k - Industry AVG
Efficiency
resulting in sales per employee of £121k, this is less efficient (£623.1k)
- Trical Pharm Ltd
£623.1k - Industry AVG
Debtor Days
it gets paid by customers after 88 days, this is later than average (58 days)
- Trical Pharm Ltd
58 days - Industry AVG
Creditor Days
its suppliers are paid after 83 days, this is slower than average (27 days)
- Trical Pharm Ltd
27 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Trical Pharm Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Trical Pharm Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 99.8%, this is a higher level of debt than the average (55%)
99.8% - Trical Pharm Ltd
55% - Industry AVG
TRICAL PHARM LTD financials
Trical Pharm Ltd's latest turnover from March 2021 is estimated at £121 thousand and the company has net assets of £47. According to their latest financial statements, we estimate that Trical Pharm Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|
| Turnover | |||||
| Other Income Or Grants | |||||
| Cost Of Sales | |||||
| Gross Profit | |||||
| Admin Expenses | |||||
| Operating Profit | |||||
| Interest Payable | |||||
| Interest Receivable | |||||
| Pre-Tax Profit | |||||
| Tax | |||||
| Profit After Tax | |||||
| Dividends Paid | |||||
| Retained Profit | |||||
| Employee Costs | |||||
| Number Of Employees | 1 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 1 | 1 | 1 | 1 | 1 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 1 | 1 | 1 | 1 | 1 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 29,356 | 12,976 | 8,488 | 29,591 | 4,219 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 |
| total current assets | 29,356 | 12,976 | 8,488 | 29,591 | 4,219 |
| total assets | 29,357 | 12,977 | 8,489 | 29,592 | 4,220 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 24,150 | 10,934 | 8,052 | 29,382 | 4,143 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 24,150 | 10,934 | 8,052 | 29,382 | 4,143 |
| loans | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 5,160 | 1,540 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 5,160 | 1,540 | 0 | 0 | 0 |
| total liabilities | 29,310 | 12,474 | 8,052 | 29,382 | 4,143 |
| net assets | 47 | 503 | 437 | 210 | 77 |
| total shareholders funds | 47 | 503 | 437 | 210 | 77 |
| Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | |||||
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 |
| Tax | |||||
| Stock | 0 | 0 | 0 | 0 | 0 |
| Debtors | 16,380 | 4,488 | -21,103 | 25,372 | 4,219 |
| Creditors | 13,216 | 2,882 | -21,330 | 25,239 | 4,143 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||
| Investing Activities | |||||
| capital expenditure | |||||
| Change in Investments | 0 | 0 | 0 | 0 | 1 |
| cash flow from investments | |||||
| Financing Activities | |||||
| Bank loans | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 3,620 | 1,540 | 0 | 0 | 0 |
| share issue | |||||
| interest | |||||
| cash flow from financing | |||||
| cash and cash equivalents | |||||
| cash | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 |
trical pharm ltd Credit Report and Business Information
Trical Pharm Ltd Competitor Analysis
Perform a competitor analysis for trical pharm ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other undefined companies, companies in MK9 area or any other competitors across 12 key performance metrics.
trical pharm ltd Ownership
TRICAL PHARM LTD group structure
Trical Pharm Ltd has no subsidiary companies.
Ultimate parent company
TRICAL PHARM LTD
10260671
trical pharm ltd directors
Trical Pharm Ltd currently has 1 director, Miss Neha Pabari serving since Jul 2016.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Miss Neha Pabari | United Kingdom | 39 years | Jul 2016 | - | Director |
P&L
March 2021turnover
121k
+6%
operating profit
-456
0%
gross margin
12.4%
-0.93%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2021net assets
47
-0.91%
total assets
29.4k
+1.26%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
trical pharm ltd company details
company number
10260671
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
July 2016
age
8
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2021
previous names
N/A
accountant
-
auditor
-
address
315 dalgin place, cambell park, MK9 4AS
Bank
-
Legal Advisor
-
trical pharm ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to trical pharm ltd.
trical pharm ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for TRICAL PHARM LTD. This can take several minutes, an email will notify you when this has completed.
trical pharm ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
